Broadcast

DanGer Shock RCT: A Decade of Data

Andreas Goetzenich, Jacob E Møller, Christian Schulze , et al

Watch time: 1h 1m 37s

Broadcast

Evidence-Based Criteria for Transcatheter Tricuspid Valve Replacement

Volker Rudolph, Sam Dawkins, Ali Vazir, et al

Watch time: 1h 1m 24s

Broadcast

Evolving Strategies in Pulmonary Embolism: From Risk Stratification to…

Stavros Konstantinides, Sylwia Sławek-Szmyt, José M Montero-Cabezas, et al

Watch time: 1h 8m 28s

Broadcast

TAVI in Small Aortic Anatomy: Optimising Planning and Outcomes

Yohei Ohno, Andrew Cook, Mehdi Eskandari, et al

Watch time: 1h 16m 40s

Michael J Mack

Watch time: 2h 44m 15s (17 videos)

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

A5 - Completeness of Culprit Artery Flow Restoration is an Independent Long-term Prognostic Marker of Patients with Cardiogenic Shock Complicating STEMI

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A5.

A2 - Admission Glucose Level is an Independent Predictor of Coronary No-reflow Phenomenon in Patients with STEMI

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A2.

A1 - Percutaneous Axillary Access for Mechanical Circulatory Support in Complex Higher-risk Indicated Procedures (CHIP)

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A1.

Tricuspid Regurgitation: A Clinical Case-Based Review Of The Edwards Cardioband™ Tricuspid Valve Reconstruction System

Published:

10 September 2018

Citation:

Interventional Cardiology Review 2018;13(3 Suppl 1):1–8.